Академический Документы
Профессиональный Документы
Культура Документы
миастеническим синдромам
Ветшев П.С., Шкроб О.С., Ипполитов И.Х., Заратьянц О.В., Пономарев А.Б.,
Мясников Г.М. Опухоли тимуса у больных миастенией // Неврологический журнал. -
1998. - №4. - С.32-35.
Гехт Б.М., Густайнис В.В., Касаткина Л.Ф., Никитин С.С., Ноздрачева Л.В.
Электромиографический и морфологический анализ изменения двигательных
единиц при миастении с тимомой и полимиозитом, терминальной полиневропатии с
миастеническим синдромом // Журн. невропатол. и психиат. - 1981. - T.81. - №11. -
С.1624-1632.
Гехт Б.М., Ильина Н.А. Нервно-мышечные болезни. - М.: Медицина, 1982. - 350 с.
Гехт Б.М., Куралесин М.Г., Гнездицкая А.В., Шагал Д.И. Влияние гормональной
терапии на уровень антител к антигенам эпителиальной ткани тимуса при
миастении // Журн. невропатол. и психиатр. - 1978. - Т.78. - №8. - С.1129-1134.
Гехт Б.М., Ланцова В.Б., Сепп Е.К. Роль антител к ацетилхолиновому рецептору в
патогенезе миастении // Неврологический журнал. - 2003. – Т.8. - Приложение 1. -
С.35-37.
Копьева Т.Н. Изменения в мышцах при миастении // Арх. пат. - 1967. - № 7. - С.57-
63.
Копьева Т.Н., Секамова С.М., Шкроб О.С. и др. Морфология вилочковой железы при
миастении у детей // Физиология, морфология и патология тимуса. - М., - 1986. -
С.69-74.
Санадзе А.Г., Гехт Б.М., Сиднев Д.В., Хлебникова Н.Н., Чугунова Н.А., Щербакова
Н.И. Антитела к ацетилхолиновому рецептору в диагностике миастении и других
форм, связанных с патологией нервно-мышечной передачи // Неврологический
журнал. - 2003. – Т.8. - Приложение 1. - С.19-21.
Санадзе А.Г., Щербакова Н.И., Давыдова Т.В., Гильванова О.В., Галкина О.И.
Кононенко Ю.В. Антитела к мышцам (антитиновые антитела) в диагностике
миастении, сочетающейся с тимомой // Неврологический журнал. - 2003. - Т.8. –
Приложение 1.- С.21-23.
Санадзе А.Г., Сиднев Д.В., Давыдова Т.В., Щербакова Н.И., Капитонова Ю.А.,
Касаткина Л.Ф., Семятицкая Р.Н., Гильванова О.В., Мененкова Е.Ю. Антитела к
мышцам (антититиновые антитела) у больных с поздним началом миастении:
клинические и электрофизиологические корреляции // Неврологический журнал. -
2003. - Т.8. - Приложение 1. - С.23-26.
Санадзе А.Г., Сиднев Д.В., Капитонова Ю.А., Галкина О.И., Давыдова Т.В. Антитела
к титину при миастении у лиц пожилого возраста и миастении, сочетающейся с
тимомой // Аллергология и иммунология. – 2004. – Т.5. - №1. – C.198-200.
Санадзе А.Г., Сиднев Д.В., Ланцова В.Б., Давыдова Т.В. Антитела к титину (MGT-30)
у больных с миастенической и немиастенической тимомой // Тезисы доклада III
Российский конгресс по патофизиологии с международным участием. - 2004. - С.26.
Сиднев Д.В., Карганов М.Ю., Щербакова Н.И., Алчинова И.Б., Санадзе А.Г. Антитела
к ацетилхолиновому рецептору у больных с различными клиническими формами
миастении и миастеническим синдромом Ламберта-Итона // Журн. невропатол. и
психиатр. – 2006 - Т. 106. - № 1. - С.53-55.
Сиднев Д.В., Санадзе А.Г., Щербакова Н.И., Давыдова Т.В., Гильванова О.В.,
Галкина О.И., Кононенко Ю.В. Антитела к мышцам (антититиновые антитела) в
диагностике миастении, сочетающейся с тимомой // Неврологический журнал. -
2003. - Т.8. - Приложение 1. – C.21-23.
Харченко В.П., Саркисов Д.С., Ветшев П.С., Галил-Оглы Г.А., Зайратьянц О.В.
Болезни вилочковой железы // М.: Триада-Х.-1998. –232 с.
Щербакова Н.И., Сидорова О.П., Мененкова Е.Ю., Галимова Г.М., Кононенко Ю.В.,
Санадзе А.Г., Неретин В.Я. Врожденный миастенический синдром, связанный с
гомозиготной точковой мутацией в промоторном регионе гена -субъединицы
рецептора ацетилхолина // Журн. невропатол. и психиат. - 2004. - Т.104. - №4. -
С.55-57.
Aarli J.A. Late-onset myasthenia gravis: a changing scene // Arch. Neurol. – 1999. -
V.56. – P.25–27.
Aarli J.A. Titin, thymoma, and myasthenia gravis // Arch. Neurol. – 2001. - V.58. -
P.869-890.
Aarli J.A., Stefansson K., Marton L., Wollmann R.L. Patient with myasthenia gravis and
thymoma have in their sera IgG autoantibodies against titin // Clin. Exp. Immunol. -
1990. - V.82. - №2. - P.284-288.
Aarli J.A., Skeie G., Mygland A., Gilhus N. Muscle striation antibodies in myasthenia
gravis. Diagnostic and functional significance // Ann. N.Y. Acad. Sci. – 1998. – V. 841. –
P. 505-515.
Aarli J.A., Romi F., Skeie G.O., Gilhus N.E. Myasthenia gravis in individuals over 40 //
Ann. N.Y. Acad. Sci. - 2003. - V.998. - P.424-431.
Abicht A., Lochmuller H. What's in the serum of seronegative MG and LEMS?: MuSK et
al. // Neurol. - 2002. – V.59. – P.1672-1673.
Almon R.R., Andrew C.G., Appel S.H. Serum globulin in myasthenia gravis ingibition of
bungarotoxin binding to acetylcholine receptors // Science. - 1974. - V.186. - P.55-57.
Amitai V., Zamir R., Vott E. HLA antigens in myasthenia gravis // Isr. J. Med. Sci. –
1979. – V.15. – P.872-873.
Antonini G., Morino S., Gradnani F., Fiorelli M. Myasthenia gravis in the elderly: a
hospital based study // Acta Neurol Scand. - 1996. - V.45. - №4 - P.260-262.
Antozzi C. Myasthenia gravis and myasthenic syndrome // Neurol. Sci. – 2003. – V.4. –
P.260-263.
Ashour M. Prevalence of ectopic thymic tissue in myasthenia gravis and its clinical
significance // J. Thorac. Cardiovasc. Surg. – 1995. – V.109. – P.632-635.
Balestra B., Moretti M., Longhi R., Mantegazza R., Clementi F, Gotti C. Antibodies
against neuronal nicotinic receptor subtypes in neurological disorders // J.
Neuroimmunol. - 2000. - V.102. – Р.89-97.
Barohn R.J., McIntire D., Herbelin L., Wolfe G.I., Nations S., Bryan W.W. Reliability
testing of the quantitative myasthenia gravis score //Ann. N.Y. Acad. Sci. - 1998. –
V.841. – P.769-772.
Barrett-Jolley R., Byrne N., Vincent A., Newsom-Davis J. Plasma from patients with
seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line //
Pflugers Arch. – 1994. – V.428. - № 5-6. – P.492-498.
Beekman R., Kuks J.B., Oosterhuis H.J. MG: diagnosis and follow-up of 100 consecutive
patients // Neurol. - 1997. - V.244. - №.2. - P.112-118.
Benveniste O., Jacobson L., Farrugia M.E., Clover L., Vincent A. MuSK antibody positive
myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse
muscle in vivo // J. Neuroimmunol. – 2005. – V.30. - №1-2. – P.41-48.
Berrih-Aknin S., Morel E., Raimond F. et al. The role of the thymus in the Myasthenia
Gravis // In: Myasthenia Gravis: biology and treatment / Ed. D. Drahman. - N.Y. - 1987.
- P.50-70.
Billre-Turc F., Padovani R., Pouget J., Serratrice G., Billre J. Late onset myasthenia: 34
cases in patients over 65 years of age // Rev.Neurol. - 1997. -V.256. - №2. - P.129-134.
Black J.L., Griesmann G.E., Erickson J., Kryzer T.J., Lamke G.T., Lennon V.A. Lambert-
Eaton myasthenic syndrome: antigenicity of recombinant human P/Q-type calcium
channel {alpha} 1 subunit putative ion pore region (domain IV, S5-S6) // Ann. N.Y.
Acad. Sci. - 1998. – V.841. – P. 691-695.
Blaes F., Beeson D., Plested P., Lang B., Vincent A. IgG from "seronegative" myasthenia
gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine
receptor // Ann Neurol. – 2000. – V.47. - №4. – P.504-510.
Bofill M., Janossy G., Willcox N. et al. Microenvironments in the normal thymus and the
thymus in myasthenia gravis // Am. J. Pathol. – 1985. – V.119. – P.462-473.
Bowen D.C., Park J.S., Bodine S. et al. Localization and regulation of MuSK at the
neuromuscular junction // Dev. Biol. – 1998. – V.199. - №2. – P.309-319.
Buckley C., Douek D., Newsom-Davis J., Vincent A., Willcox N. Mature, long-lived CD4+
and CD8+T cells are generated by the thymoma in myasthenia gravis // Ann. Neurol. –
2001.- V.50. - №1. – P.64-72.
Buckley C., Newsom-Davis J., Willcox N., Vincent A. Do titin and cytokine antibodies in
MG patients predict thymoma or thymoma recurrence? // J. Neurology. – 2001. – V.57.
- №9. - P.1579-1582.
Burges J., Vincent A., Molenaar P.C., Newsom-Davis J., Peers C., Wray D. Passive
transfer of seronegative myasthenia gravis to mice // Muscle & Nerve. – 1994. – V.17. -
№12. – P.1393-1400.
Castaigne P., Castaigne A. Problems of myasthenia // Clin. Med. – 1973. – V.51. – P.10-
13.
Chen X.J, Qiao J, Xiao B.G., Lu C.Z. The significance of titin antibodies in myasthenia
gravis – correlation with thymoma and severity of myastenia gravis // J. Neurol. - 2004.
– V.251. - P.1006-1011.
Clouston P.D., Saper C.B., Arbizu T. et al. Cerebellar degeneration, cancer, and the
Lambert-Eaton myasthenic syndrome // Neurology. – 1992. – V.42. – P.1944-1950.
Compston D.A.S., Vinsent A., Newsom-Davis J., Batchelor J.R. Clinical pathological HLA
antigen and immunological evidence for disease heterogeneity in myasthenia gravis //
Brain. – 1980. - №103. – P.579-601.
Cull-Candy S.G., Miledy R., Trautmann A., Uchitel O.B. The release of transmitter at
normal, myasthenia gravis and myasthenic syndrome affected human end-plates // J.
Physiol. (Lond.). - 1980. - V.299. - P.621-638.
Davila H.M. Molecular and functional diversity of voltage-gated calcium channels // Ann.
N.Y. Acad. Sci. – 1999. - V.868. – P.102-117.
Desmedt J.E. Presynaptic mechanisms in myasthenia gravis // Ann. N.Y. Acad. Sci. -
1966. - V.135. - P.209-246.
Desmedt J.E. The neuromuscular disorder on myasthenia gravis. Electrical and
mechanical response to nerve stimulation in hand muscles // New Developments in EMG
and Clin. Neurophysiol. / Desmedt J.E. (Ed.). - Basel: Karger. - 1973. - P.241-304.
Dhall G., Ginsburg H.B., Bodenstein L., Fefferman N.R., Greco M.A., Chang M.W.,
Gardner S. Thymoma in children: report of two cases and review of literature // J.
Pediatr. Hematol. Oncol. - 2004. - V.26. - №10. - P.681-685.
Drachman D.B. Myasthenia gravis. Biology and Treatment - New York. - 1987. – 912 p.
Drachman D.B., Adams R.N., Josifek L.F., Self S.G. Functional activities of
autoantibodies to acetylcholine receptors and the clinical severity of myasthenia
gravis // N.Engl. J. Med. - 1982. - V.307. - P.769-773.
Dropcho E.J., Stanton C., Oh S.J. Neuronal antinuclear antibodies in a patient with
Lambert-Eaton myasthenic syndrome and small cell lung carcinoma // Neurol. – 1989. –
V.39. – P.249-251.
El Far O., Marqueze B., Leveque C. et al. Antigens associated with N- and L-type calcium
channels in Lambert-Eaton myasthenic syndrome // J. Neurochem. – 1995. – V.64. –
P.1696-1702.
Engel A.G. Molecular biology of end-plate diseases // In M.M. Salpeter (Ed.), The
vertebrate neuromuskular junction // New York: Alan R. Liss. – 1987. – V.10. - P.361-
424.
Engel A.G. // The investigation of congenital myasthenic syndromes // Ann. N.Y. Acad.
Sci. - 1993. - V.681. - P.425-435.
Engel A.G., Lambert E.H., Mulder D.M. et al. A newly recognized congenital myasthenic
syndrоme attributed to a prolonged open time of the acetylcholine-induced ion channe //
Ann. Neurol. - 1982. – V.11. – P.553-569.
Engel A.G., Ohno K., Bouzat C. et. al. End-plate acetylcholine receptor deficiency due to
nonsence mutation in the - subunit // Ann. Neurol. – 1996. – V.40. – P.810-817.
Engel A.G., Ohno K., Milone M. et al. New mutations in acetylcholine receptor subunit
genes reveal heterogeneity in slow-channel congenital myasthenic syndrоme // Hum.
Mol. Genet. – 1996. - V.5. – P.1217-1227.
Engel A.G., Ohno K., Sine S.M. Congenital myasthenic syndrоmes. In: Engel A.G.,
editor. Myasthenia gravis and myasthenic disorders // New York: Oxford University
Press. - 1999. – Р. 251-297.
Engel A.G., Ohno K., Shen X.-M., Milone M., Tsujno A. Congenital myasthenic
syndromes in the molecular era // Acta Myologica. – 2000. – V.19. - №4 – P.5-21.
Engel A.G., Tsudjihata M., Lindstrom J.M., Lennon V.A. The motor end-plate in
myasthenia gravis and in experimental auto-immune myasthenia. A quantitative
ultrastructural study // Ann. N.Y. Acad. Sci. - 1976. – V.274. – P.60-79.
Engel W.K. Brief, small, abundant motor unit action potentials: A further critique of
electromyographic interpretation // Neurol. (Minneap.). - 1975. - V.25. - P.173-176.
Evoli A., Batocchi A.P., Tonali P.A. Practical guide to the recognition and management of
Myasthenia gravis // J. Drugs. - 1996. - V.52. - №5. - P.662-670.
Fambrough D., Hartsell H.C., Rash J.E., Ritchie A.K. Receptor properties of developing
muscle // Ann. N.Y. Acad. Sci. - 1974. – V.228. - P.47-61.
Farrugia M.E., Kennett R.P. Turns amplitude analysis of the orbicularis oculi and oris
muscles // Clin. Neurophysiol. – 2005. – V.116. - №11. – P.2550-2559.
Farrugia M.E., Kennett R.P., Newsom-Davis J., Hilton-Jones D., Vincent A. Single-fiber
electromyography in limb and facial muscles in muscle-specific kinase antibody and
acetylcholine receptor antibody myasthenia gravis // Muscle & Nerve. – 2006. – V.33. -
№4. – P.568-570.
Gautel M., Lakey A., Barlow D.P., Holmes Z., Mygland A., Aarli J.A., Gilhus N.E. Titin
antibodies in myasthenia gravis: identification of a major immunogenic region of titin //
J. Neurology. - 1993. - V.43. - №8. - P.1581-1585.
Geld H., Strauss A.J. Myasthenia gravis: immunologic relationship between muscle and
thymus // Lancet. - 1969. - V.1. - P.57-60.
Gomez C.M., Maselli R., Gammack J. et al. A - subunit mutation in the acetylcholine
receptor gate causes severe slow-channel syndrоme // Ann. Neurol. – 1996. – V.39. -
P.712-723.
Gotti C., Balestra B., Mantegazza R., Tzartos S., Moretti M., Clementi F. Detection of
antibody subpopulations in myasthenia gravis using a non radioactive new enzyme
immunoassay // Muscle & Nerve. - 1997. - V.20. - P.800-808.
Granzier H., Kellermayer M., Helmes M., Trombitas K. Titin elasticity and mechanism of
passive force development in rat cardiac myocytes probed by thin-filament extraction //
Biophys. J. – 1997. – V.73. - №4. – P.2043-2053.
Graus F., Lang B., Pozo-Rosich P., Saiz A., Casamitjana R., Vincent A. P/Q type calcium-
channel antibodies in paraneoplastic cerebellar degeneration with lung cancer // Neurol.
- 2002. – V.59. – P.764-766.
Gutmann L., Phillips L.H. Trends in the association of the LEMS with carcinoma //
Neurology. - 1992. - V.42. - P.848-850.
Hajela R.K, Atchison W.D. The proteins synaptotagmin and syntaxin are not general
targets of Lambert-Eaton myasthenic syndrome autoantibody // J. Neurochem. – 1995.
– V.64. – P.1245-1251.
Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., Vincent A. Auto-
antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis
without acetylcholine receptor antibodies // Nat. Med. - 2001. - V.7. - №.3. - P.365-368.
Hodgkin P.D., Yamashita L.C., Seymour B., Coffman R.L., Kehry M.R. Membranes from
both Th1 and Th2 T cell clones stimulate B cell proliferation and prepare B cells for
lymphokine-induced differentiation to secrete Ig // J. Immunol. – 1991. – V.147. - №11.
– P.3696-3702.
Hohlfeld R., Wekerle H. The role of the thymus in myasthenia gravis // Adv.
Neuroimmunol. – 1994. – V.4. – P.373-386.
Horowits R., Kempner E.S., Bisher M.E., Podolsky R.J. A physiological role for titin and
nebulin in skeletal muscle // Nature. – 1986. – V.323. – P.160-164.
Howard F.M., Lennon V.A., Finley J., Matsumoto J., Elveback L.R. Clinical correlations of
antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia
gravis// Ann. N.Y. Acad. Sci. - 1987. - V.505. - P.526-538.
Huangy M., Kivisakk P., Ozenci V., Pirskanen R., Link H. Increased levels of circulating
acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for
myasthenia gravis // Curr. Opin. Rheumatol. - 1999. - V.11. - №.1. - P.483-488.
Jaretzki A., Wolff M. "Maximal" thymectomy for myasthenia gravis. Surgical anatomy
and operative technique // J. Thorac. Cardiovasc. Surg. – 1988. – V.96. – P.711-716.
Kaminski H.J., Ruff R.L. Insights into possible skeletal muscle nicotinic acetylcholine
receptor (AChR) changes in some congenital myasthenias from physiological studies,
point mutations, and subunit substitutions of the AChR. // Ann. N.Y. Acad. Sci. - 1993. -
V.681. - P.435-450.
Karachunski P.I., Ostlie N.S., Okita D.K., Conti-Fine B.M. Interleukin-4 deficiency
facilitates development of experimental myasthenia gravis and precludes its prevention
by nasal administration of CD4+ epitope sequences of the acetylcholine receptor // J.
Neuroimmunol. – 1999. – V.95. - №1-2. – P.73-84.
Karachunski P.I., Ostlie N.S., Monfardini C., Conti-Fine B.M. Absence of IFN-gamma or
IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice // J.
Immunol. – 2000. – V.164. - №10. – P.5236-5244.
Keanes G. The results of thymectomy in myasthenia gravis // Br. Med. J. - 1949. – V.2.
- P.611-616.
Kelly J.J., Daube J.R., Lennon V.A., Howard F.M. The laboratory diagnosis of mild
myasthenia gravis // Ann. Neurol. Neurosurg. - 1982. – V.12. - P.238-242.
Kennel P.F., Vilquin J.T., Braun S., Fonteneau P., Warter J.M., Poindron P. Myasthenia
gravis: comparative autoantibody assays using human muscle, TE671 and
glucocorticoid-treated TE671 cells as sources of antigen // Clin. Immunol.
Immunopathol. - 1995. - V.74. - P.293-296.
Kim Y.I., Nam T.S., Kim S.H., Viglione M.P., Kim J. Specificity of the Lambert-Eaton
syndrome antibodies: downregulation of P/Q-type calcium channels in bovine adrenal
chromaffin cells // Ann. N.Y. Acad. Sci. - 1998. – V.841. – P.677-683
Kondo K, Monden Y. Myasthenia gravis appearing after thymectomy for thymoma // Eur.
J. Cardiothorac. Surg. – 2005. – V. 28. – P. 22-25.
Kondo K., Monden Y. Thymoma and myasthenia gravis: a clinical study of 1089 patients
from Japan // Ann. Thorac. Surg. - 2005. – V.79. - P.219-224.
Krarup С. Electrical and mechanical responses in the platisma and in the adductor
pollicis muscle in patients with myasthenia gravis // J. Neurol., Neurosurg., Psychiat. -
1977. - V.40. - P.241-249.
Krarup C. Evoked responses in normal and diseased muscle with particular reference to
twitch potentiation // Acta Neurol. Scand. - 1984. - V.68. - P.269-315.
Krarup C., Horowitz S.H. Evoked responses of the elbow flexors in control subjects and
in myopathy patients // Muscle & Nerve. – 1979. – V.6. – P.465-477.
Kuks J.B., Limburg P.C., Horst G., Dijksterhuis J., Oosterhuis H.J Antibodies to skeletal
muscle in myasthenia gravis. Diagnostic value for the detection of thymoma // J. Neurol.
Sci. – 1993. – V.119. – P.183-188.
Kuks J.B., Limburg P.C., Horst G., Oosterhuis H.J. Antibodies to skeletal muscle in
myastrenia gravis. Prevalence in non-thymoma patiens // J. Neurol. Sci. - 1993. -
V.120. - P.78-81.
Labiet S., Kolmerer B. Titin: giant proteins in charge of muscle ultrastructure and
elasticity // J. Sci. - 1995. – V.270. – P.293-296.
Lambert E.H., Eaton L.M., Rooke E.D. Defect of neuromuscular conduction associated
with malignant neoplasms // Am. J. Physiol. - 1956. – V. 187. – P.612-616.
Lang B., Newsom-Davis J., Wray D., Vincent A., Murray. N. Autoimmune aetiology for
myasthenic (Eaton–Lambert) syndrome // Lancet. – 1981. – V. 2. – P.224–226.
Lang B., Pinto A., Giovannini F., Newsom-Davis J., Vincent A. Pathogenic autoantibodies
in the Lambert-Eaton myasthenic syndrome // Ann. N.Y. Acad. Sci. - 2003. - V.998. -
P.187-195.
Lang B., Waterman S., Pinto A., Jones D., Moss F., Boot J., Brust P., Williams M.,
Stauderman K., Harpold M., Motomura M., Moll J.W., Vincent A., Newsom-Davis J. The
role of autoantibodies in Lambert–Eaton myasthenic syndrome // Ann. N.Y. Acad. Sci. –
1998. – V.841. – P.598–605.
Lauritzen M., Smith T., Fischer-Hansen B., Sparup J., Olesen J. Eaton-Lambert
syndrome and malignant thymoma // Neurol. – 1980. – V.30. – P.634-638.
Leite M.I., Strobel P., Jones M. et al. Fewer thymic changes in MuSK antibody-positive
than in MuSK antibody-negative MG // Ann. Neurol. – 2005. – V.57. - №3. – P.444-448.
Lennon V.A. Serological diagnosis of myasthenia gravis and Lambert- Eaton myasthenic
syndrome // Handook of Myasthenia gravis / R. Lisak, Ed., Marcel Dekker. - 1994. - V.7.
- P.149-164.
Lennon V.A. Serological profile of myasthenia gravis and distinction from the Lambert-
Eaton myasthenic syndrome // Neurology. – 1997. – V.48. - №5. – P.23-27.
Lennon V.A., Ermilov L.G., Szurszewski J.H., Vernino S. Immunization with neuronal
nicotinic acetylcholine receptor induces neurological autoimmune disease // J. Clin.
Invest. - 2003. - V.111. – P.907-913.
Lennon V.A., Kryzer Th.J., Griesmann G.E., O’Suilleabhain P.E., Windebank A.J.,
Woppmann A., Miljanich G.P., Lambert E.H. Calcium channel antibodies in the Lambert-
Eaton syndrome and other paraneoplastic syndromes // N.Engl. J. Med. - 1995. - V.332.
- P.1467-1474.
Lindberg C., Andersen O., Larsson S., Oden A. Remission rate after thymectomy in
myasthenia gravis when the bias of immunosuppressive therapy is eliminated // Acta
Neurol. Scand. – 1992. – V.86. – P.323-328.
Lindstrom J. Acetylcholine receptor and myasthenia //Muscle & Nerve. - 2000. - № 23. -
P.453-477.
Lindstrom J., Lambert E.H. Content of acetylcholine receptor and antibodies bound to
receptor to myasthenia gravis, experimental autoimmune myasthenia gravis and Eaton-
Lambert syndrome // Neurol. (Minneap.). - 1978. - V.28. - P.130-138.
Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis // Adv. Immunol. - 1988. - V.42. -
P.233-284.
Link J., Soderstrom M., Ljungdahl A., Hojeberg B., Olsson T., Xu Z., Fredrikson S., Wang
Z.Y., Link H. Organ-specific autoantigens induce interferon-gamma and interleukin-4
mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis //
Neurol. – 1994. – V.44. - №4. – P.728-734.
Lisak R. Myasthenia Gravis // In: Surgery of the thymus/ Ed. J.-C. Givel. - Berlin.
Springer Verlang. - 1990. - P.165-181.
Luebke E., Freiburg A., Skeie G.O., Kolmerer B., Labeit S., Aarli J.A., Gilhus N.E.
Striational autoantibodies in miasthenia gravis patients recognize I-band titin epitopes //
J. Neuroimmunol. – 1988. – V.81. - №1-2. – P.98-108.
Marino M., Muller-Hermelink H.K. Thymoma and thymic carcinoma. Relation of thymoma
epithelial cells to the cortical and medullary differentiation of thymus // Virchows Arch.
Pathol. Anat. Histopathol. - 1985. – V.407. – P.119-149.
Marx A., Osborne M., Tzartos S. et al. // A striational muscle antigen and myasthenia
gravis- associated thymomas share an acetylcholine receptor epitope // Dev. Immunol. -
1992. - V.2 - P.77-83.
Maruyama K. Connectin, an elastic protein of striated muscle // Biophys. Chem. - 1994.
- V.50. - P.73-85.
Maruyama K. Connectin / titin, giant elastic protein of muscle // FASEB J. - 1997. - V.11.
- P.341-345.
Masaoka A., Yamakawa Y., Niwa H. et al. Extended thymectomy for myasthenia gravis
patients: a 20-year review // Ann. Thorac. Surg. – 1996. – V.62. – P.853-859.
Matsumoto R., Motomura M., Yoshimura T., Kohara N., Kato T. Myasthenia gravis with
electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of
serum autoantibodies assay and neuromuscular junction biopsy // Rinsho Shinkeigaku. –
1999. – V.39. - №5. – P.531-537.
McConville J., Farrugia M.E., Beeson D., Kishore U., Metcalfe R., Newsom-Davis J.,
Vincent A. Detection and characterization of MuSK antibodies in seronegative
myasthenia gravis // Ann. Neurol. – 2004. – V.55. - №4. – P.580-584.
Meager A., Wadhwa M., Dilger P., Bird C., Thorpe R., Newsom-Davis J., Willcox N. Anti-
cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies
against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma
and/or myasthenia gravis // Clin Exp Immunol. - 2003. - V.132. - №1. - P.128-136.
Milone M., Wang H-L, Ohno K. et al. Slow-channel syndrome caused by enhanced
activation, desensitization, and agonist binding affinity due to mutation in the M2
domain of the acetylcholine receptor - subunit // J. Neurosci. – 1997. – V.17. – P.
5651-5665.
Monden Y., Nakahara K, Nanijo S. Et al. Invasive thymoma with myastenia gravis //
Cancer. – 1984. – V.54. - P.2513-2518.
Motomura M., Johnston I., Lang B., Vincent A., Newsom-Davis J. An improved diagnostic
assay for Lambert–Eaton myasthenic syndrome // J. Neurol., Neurosurg., Psychiat. –
1995. – V.58. – P.85–87.
Motomura M., Lang B., Johnston I., Palace J., Vincent A., Newsom-Davis J. Incidence of
serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-
Eaton myasthenic syndrome // J. Neurol. Sci. – 1997. – V.147. – P.35-42.
Muller-Hermilink H., Marino M., Palestro G. Pathology of thymic epithelial tumors // The
Human Thimyc / Ed. H. Muller-Hermilink.-Berlin, etc.: Springer Verlag. - 1986. - P.207-
269.
Muller-Hermelink H., Marx A., Geuder K., Kirchner T. The pathological basis of
thymoma-associated myasthenia gravis // Ann. N.Y. Acad. Sci. - 1994. - V.681. - P.56-
65.
Nagel A., Engel A.G., Walls T.J. et al. Congenital end-plate acetylcholine receptor
deficiency and short channel open time // Ann. N.Y. Acad. Sci. – 1993. - V.681. - P.509-
514.
Nastuk W.L., Strauss A.J., Osserman K.E. Search for a neuromuscular blocking agent in
the blood of patients with myasthenia gravis // Am. J. Med. – 1959. – V.26. - №3. –
P.394-409.
Negri S., Caraceni T. Myasthenia gravis: parameters the motor unit potentials and
modifications induced by endrophonium chloride // Clinical studies in myology / B.A.
Kakulas (Ed.), - Amsterdam: Excerpta medica. - 1973. - P.381-395.
Nemoto Y., Kuwabara S., Misawa S., Kawaguchi N., Hattori T., Takamori M., Vincent A.
Patterns and severity of neuromuscular transmission failure in seronegative myasthenia
gravis // J. Neurol., Neurosurg., Psychiat. – 2005. – V.76. - №5. – P.714-718.
Oberman W.M., Gautel M., Weber K., Furst D.O. Molecular structure of the sarcomeric M
band: mapping of titin and myosin binding domains in myomesin and the identification
of a protein regulatory phosphorylation site in myomesin // EMBO J. – 1997. – V.16. –
P.211-220.
Oh S.J. Repetitive nerve stimulation test // Methods in Clin. Neurophys. - 1992. - V.3. -
№1. - 17 p.
Oh S.J., Dwyer D.S., Bradley R.J. Overlap myasthenic syndrome: combined myasthenia
gravis and Eaton-Lambert syndrome // Neurology. - 1987. – V. 37. – P.1411-1414.
Oh S.J., Kim D.E., Kuruoglu R., Brooks J., Claussen G. Electrophysiological and clinical
correlations in the Lambert-Eaton myasthenic syndrome // Muscle & Nerve. - 1996. –
V.19. – P.903-906.
Oh S.J., Sher E. MG and LEMS overlap syndrome: case report with electrophysiological
and immunological evidence // Clin. Neurophysiol. – 2005. – V.116. - №5. – P.1167-
1171.
Ohta K., Shigemoto K., Kubo S., Maruyama N., Abe Y., Ueda N., Ohta M. MuSK
antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG // Neurology. –
2004. – V.62. – P.2132-2133.
Olanow C.W., Lane R.J.M., Roses A.D. Thymectomy in juvenile myasthenia gravis //
Neurol. - 1981. - V.31. - P.97.
Oosterhuis H., Hootsmans W., Veenhuyzen H.B., Zadelhoff J. The mean duration of
motor unit action potentials in patients with myasthenia gravis // Electroenceph. Clin.
Neurophysiol. – 1972. - V.32. - P.697-700.
Ouchi M., Konnai T., Shimizu M., Shibuya T., Suzuki H. Results and problems of
thymectomy in myasthenia gravis over 65 years old // Kyobu Geka. - 1999. - V.52. -
№13. - P.1095-1000.
Ozdemir C., Young R.R. Electrical testing in myasthenia gravis // Ann. N.Y. Acad. Sci. -
1972. - V.183. - P.278-302.
Ozdemir C., Young R.R. The results to be expected from electrical testing in the
diagnosis of myasthenia gravis // Ann. N.Y. Acad. Sci. - 1980. - V.274. - P.203-222.
Patrick J., Lindstrom J., Culp B., McMillan J. Studies of purified AChR and
antiacetylcholine receptor antibodies // Proc. Nat. Acad. Sci. - 1973. - V.70. - P.3334-
3338.
Penn A.S., Scotland D.L., Rowland L.P. Immunology of muscle diseases // Res. Publ.
Assoc. Res. Nerv. Ment. - 1971. - V.49. - P.215-240.
Pfuhl M., Pastore A. Tertiary structure of an immunoglobulin-like domain from the giant
muscle protein titin: a new member of the I set // Structure. – 1995. – V.15. - №4. –
P.391-401.
Ragheb S., Mohamed M., Lisak R.P. Myasthenia gravis patients, but not healthy
subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine
receptor // J. Neuroimmunol. – 2005. – V.159. - №1-2. – P.1137-1145.
Rena O., Papalia E., Maggi G., Oliaro A., Ruffini E., Filosso P., Mancuso M., Novero D.,
Casadio C. World Health Organization histologic classification: an independent prognostic
factor in resected thymomas // Lung Cancer. – 2005. – V.50. – P.59-66.
Romi F., Gilhus N.E., Aarli J.A. Thymectomy and muscle antibodies in myasthenia
gravis // Tidsskr. Nor. Laegeforen. – 2004. – V.124. - №5. – P.629-631.
Romi F., Gilhus N.E., Varhaug J.E., Myking A., Skeie G.O., Aarli J.A. Thymectomy and
anti-muscle autoantibodies in late-onset myasthenia gravis // Eur. J. Neurol. - 2002. –
V.1. - P.55-61.
Romi F., Gilhus N.E., Varhaug J.E., Myking A., Skeie G.O., Aarli J.A. Thymectomy and
antimuscle antibodies in nonthymomatous myasthenia gravis // Ann N Y Acad Sci. -
2003. – V.998. - P.481-490.
Romi F., Gilhus N.E., Aarli J.A. Myasthenia gravis: clinical, immunological and
therapeutic advances // Acta Neurol. Scand. – 2005. – V.111. - №2 – P.134-141.
Romi F., Gilhus N.E., Aarli J.A. Myasthenia gravis: disease severity and prognosis // Acta
Neurol. Scand. – 2006. – V.183. – P.24-25.
Romi F., Kristoffersen E.K., Aarli J.A., Gilhus N.E. The role of complement in myasthenia
gravis: serological evidence of complement consumption in vivo // J. Neuroimmunol. –
2005. – V.158. - №1-2. – P.191-194.
Romi F., Skeie G.O., Aarli J.A., Gilhus N.E. The severity myasthenia gravis correlates
with the serum concentration of titin and ryanodine receptor antibodies.// Arch Neurol. –
2000. – V. 57. – P.1596-1600.
Romi F., Skeie G.O., Gilhus N.E., Aarli J.A. Striational antibodies in myasthenia gravis:
reactivity and possible clinical significance.// Arch Neurol. – 2005. – V.62. – P.442-446.
Rosai J., Levin G. Tumors of the Thymus // Atlas of tumor pathology. - Washington:
Armed Forces Inst. Of Pathol. - 1976. - P.26-33, 133-137.
Roses A.D., Olanov C.W., McAdams M.W., Lane R. No direct correlation between serum
antyacetylcholine receptor antibody levels and clinical state of individual patient with
myasthenia gravis // Neurology. – 1981. – V.31. – P.220-224.
Sahashi K.A., Engel A.G., Lindstrom J., Lambert E.H., Lennon V.A. Ultrastructural
localization of immune complexes (Ig G and C3) at the end-plate in experimental
autoimmune myasthenia gravis // Neurol. - 1978. - V.37. - P.212-223.
Sanders D.B., El-Salem K., Massey J.M., McConville J., Vincent A. Clinical aspects of
MuSK antibody positive seronegative MG // Neurology. – 2003. – V.24. - №12. –
P.1978-1980.
Scadding G.K., Thomas H.C., Havard C.W. The immunological effects of thymectomy in
myasthenia gravis // Clin. Experim. Immunol. - 1979. - V.36. - P.205-213.
Schulze W., Laczkovics A., Richl J., Sindern E. Thymectomy in myasthenia gravis - an
analisis of current status // Chirurg. - 1998. - V.69. - №12. - P.1345-1351.
Sela B.A. Titin: some aspects of the largest protein in the body // Harefuah. – 2002. –
V.131. – P. 631-635.
Selcen D., Fukuda T., Shen X.M., Engel A.G. Are MuSK antibodies the primary cause of
myasthenic symptoms? // Neurol. – 2004. – V.62. - №11. – P.1945-1950.
Seybold M.E., Lindstrom J.M. Serial antiacetylcholine receptor antibody titers in patients
with myasthenia gravis: effects of steroid therapy // Plasmapheresis and the
immunology of myasthenia gravis / Dau P.C. (Ed.). - 1979. - P.307-314.
Sharshar T., Lacroix-Desmazes S., Mouthon L., Kaveri S., Gajdos P., Kazatchkine M.D.
Selective impairment of serum antibody repertoires toward muscle and thymus antigens
in patient with myasthenia gravis // J. Immunol. – 1998. – V.28. - №8. – P.2344-2354.
Sher E., Codignola A., Passafaro M., Tarroni P., Magnelli V., Carbone E., Clementi F.
Nicotinic receptors and calcium channels in small cell lung carcinoma: functional role,
modulation, and autoimmunity // Ann. N.Y. Acad. Sci. - 1998. – V.841. – P.606-624.
Shiono H., Wong Y.L., Matthews I., Liu J.L., Zhang W., Sims G., Meager A., Beeson D.,
Vincent A., Willcox N. Spontaneous production of anti-IFN-alpha and anti-IL-12
autoantibodies by thymoma cells from myasthenia gravis patients suggests
autoimmunization in the tumor // Int. Immunol. – 2003. – V.15. - №8. – P.903-913.
Shiraishi H., Motomura M., Yoshimura T., Fukudome T., Fukuda T., Nakao Y., Tsujihata
M., Vincent A., Eguchi K. Acetylcholine receptors loss and postsynaptic damage in MuSK
antibody-positive myasthenia gravis // Ann Neurol. - 2005. – V.57. - №2. – P.289-293.
Simpson J.A. Myasthenia gravis, a new hypothesis // Scotland Med. J. - 1960. - V.5. -
P.419-436.
Skeie G.O. Skeletal muscle titin: physiology and pathophysiology // Cell. Mol. Life Sci. –
2000. – V. 57. – P. 1570-1576.
Skeie G.O., Mygland A., Aarli J., Gilhus N.E. Titin antibodies in patients with late-onset
myasthenia gravis: clinical correlations // Autoimmunity. – 1995. – V.20. – P. 99-104.
Skeie G.O., Romi F., Aarli J.A., Bentsen P.T., Gilhus N.E. Pathogenesis of myositis and
myasthenia associated with titin and ryanodine receptor antibodies // Ann N.Y. Acad.
Sci. - 2003. – V.998. – P.343–350.
Somnier F.E. Myasthenia gravis // J. Dan. Med. Bull. - 1996. - V.43. - №1. - P.1-10.
Somnier F.E., Engel A.G. The occurrence of anti-titin antibodies and thymomas: a
population survery of MG 1970-1999 // Neurology. - 2002. – V.9. - P.92-98.
Somnier F.E., Skeie G.O., Aarli J.A., Trojaborg W. EMG evidence of myopathy and the
occurrence of titin autoantibodies in patient with myasthenia gravis // Europ. J. Neurol. -
1999. - №6. - P.555-563.
Stalberg E., Antoni L. Electrophysiological cross section of the motor unit // J. Neurol.,
Neurosurg., Psychiat. – 1980. – V.43. – P.469-474.
Stalberg E., Fawsett P.R Macro EMG in healthy subjects of different ages // J. Neurol.,
Neurosurg., Psychiat. – 1982. - V.45. - P.870-878.
Sprent J. The thymus and T-cell tolerance // Ann. N.Y. Acad. Sci. - 1993. - V.681. - P.5-
15.
Sprent J., Gao E.K., Kanagawa O., Webb S.R. T-cell selection in the thymus // Princess
Takamatsu Symp. – 1988. – V.19. – P.127-136.
Strauss A.J., Kemp P.G. Serum autoantibodies in myasthenia gravis: relective affinity for
J-bands of striated muscle as a guede to identification of antigen (S) // J. Immunol. -
1967. - V.99. - P.945-953.
Sund K.K., Skeie G.O., Gilhus N.E., Aarli J., Varhaug J.E. Diagnosis of thymoma and
thymic atrophy in patients with myasthenia gravis // Tidsskr. Nor. Laegeforen. - 1997. -
V.117. - P.4212-4214.
Suzuki S., Satoh T., Yasuoka H., Hamaguchi Y., Tanaka K., Kawakami Y., Suzuki N.,
Kuwana M. Novel autoantibodies to a form of myasthenia gravis // J. Neuroimmunol. –
2005. – V.170. - №1-2. – P.141-149.
Tim R.W., Massey J.M., Sanders D.B. Lambert-Eaton syndrome (LEMS): Clinical and
electrodiagnostic features and response to therapy in 59 patients // Ann. N.Y. Acad. Sci.
– 1998. – V.841. – P. 823-826.
Tim R.W., Sanders D.B. Repetitive nerve stimulation studies in the Lambert-Eaton
myasthenic syndrome // Muscle & Nerve. - 1994. - V.17. - P.995-1001.
Tseng Y.L., Chang J.M., Shu I.L., Wu M.H. Myasthenia gravis developed 30 months after
resection of recurrent thymoma // Eur. J. Cardiothorac. Surg. – 2006. – V.29. – P. 268-
269.
Twomey J.J., Lewis V.M., Patten B.M., Goldstein G., Good R.A. Myasthenia gravis,
thymectomy and serum thymic hormone activity // Am. J. Med. – 1979. – V.66. – P.
639-643.
Valenzuela D.M., Stitt T.N., DiStefano P.S., Rojas E., Mattsson K., Compton D.L., Nunez
L., Park J.S., Stark J.L., Gies D.R et al. Receptor tyrosine kinase specific for the skeletal
muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and
after injury // Neuron. 1995. – V.15. - №3. – P.573-584.
Verley J.M., Hollmann K.H., Thymoma. A comparative study of clinical stages, histologic
features and survival in 200 cases // Cancer. – 1985. – V.55. - №5. – P.1074-1086.
Vernino S., Auger R.G., Emslie-Smith A.M., Harper C.V., Lennon V.A. Myasthenia,
thymoma, presynaptic antibodies and a continuum of neuromuscular hyperexcitability //
Neurol. - 1999. - V.53. - №.6. - P.1233-1239.
Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies
to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies // N.
Engl. J. Med. - 2000. – V.343. – P.847-855.
Vieira M.L., Cailatt-Zucman S., Gaidos P. Identification by genomic of non DR3 HLA class
11 gens associated with myasthenia gravis // J. Neuroimmunol. - 1993. - V.47. - P.115-
122.
Vincent A., Beeson D., Lang B. Molecular targets for autoimmune and genetic disorders
of neuromuscular transmission // Eur. J. Biochem. - 2000. - V.267. - P.6717-6728.
Vincent A., Dalton P., Clover L., Palace J., Lang B. Antibodies to neuronal targets in
neurological and psychiatric diseases // Ann. N.Y. Acad. Sci. – 2003. – V.992. – P.48-55.
Voltz R., Albrich W., Nagele A., Schumm F., Wick M., Freiburg A., Gautel M., Thaler H.,
Aarli J., Kirchner T., Hohlfeld R. // Paraneoplastic myasthenia gravis: detection of anti-
MGT30 (titin) antibodies predicts thymic epithelial tumor // Neurol. - 1997. - V. 49. -
P.1454-1457.
Voltz R., Albrich W., Hohlfeld R., Nagel D., Wick M. et al. Anti-titin antibodies are not
associated with a specific thymoma histology // J. Neurol. Neurosurg. Psychiat. – 2003.
– V.74. – P. 282.
Wang K. Cytoskeletal matrix in striated muscle: the role of titin, nebulin and
intermediate filaments // Adv. Exp. Med. Biol. – 1984. – V.170. – P.285-305.
Wang K., McCarter R., Wright J., Beverly J., Ramirez-Mitchell R. Regulation of skeletal
muscle stiffness and elasticity by titin isoforms: a test of the segmental extension model
of resting tension // Proc. Natl. Acad. Sci. U S A. – 1991. – V.88. – P.7101-7105.
Wang K., McCarter R., Wright J., Beverly J., Ramirez-Mitchell R. Viscoelasticity of the
sarcomere matrix of skeletal muscles. The titin-myosin composite filament is a dual-
stage molecular spring // Biophys. J. – 1993. – V.64. - №4. – P.1161-1177.
Wang Z.Y., Okita D.K., Howard J.Jr., Conti-Fine B.M. Th1 epitope repertoire on the alpha
subunit of human muscle acetylcholine receptor in myasthenia gravis // Neurol. – 1997.
– V.48. - №6. – P. 1643-1653.
Wekerle H. The thymus in myasthenia gravis // Ann. N. Y. Acad. Sci. – 1993. – V.681. –
P.47-55.
Willcox N., Schluep M., Ritter M. A., Schuurman H. J., Newsom-Davis J., Christenson B.
Myasthenic and nonmyasthenic thymoma: an expansion of a minor cortical epithelial cell
subser? // Am. J. Pathol. – 1987. – V.127. - P. 447–460.
Wirtz P.W., Lang B., Graus F. et al. P/Q-type calcium channel antibodies, Lambert-Eaton
myasthenic syndrome and survival in small cell lung cancer // J. Neuroimmunol. – 2005.
– V.5. – P.16-24.
Wray D., Porter V. Calcium channel types at the neuromuscular junction // Ann. N.Y.
Acad. Sci. - 1994. - V.681. - P.356-367.
Yeh J.H., Chen W.H., Chiu H.C., Vincent A. Low frequency of MuSK antibody in
generalized seronegative myasthenia gravis among Chinese // Neurol. – 2004. – V.62. -
№11. – P.2131-2132.
Zhang G.X., Ma C.G., Xiao B.G., van de Meide P.H., Link H. Autoreactive T cell responses
and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis
in Wistar Furth rats // Eur. J. Immunol. – 1996. – V.26. - №11. – P.2552-2558.
Zhang G.X., Navikas V., Link H. Cytokines and the pathogenesis of myasthenia gravis //
Muscle & Nerve. - 1997. – V.20. - №5. – P.543-551.
Zhang W., Lie J.L., Meager A., Newsom-Davis J., Willcox N. Autoantibodies to IL-12 in
myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of
healthy CD4+ T cells // J. Neuroimmunol. - 2003. - V.139. - №1-2. – P.102-108.